| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
180,310,000 |
| Market
Cap: |
41.24(B) |
| Last
Volume: |
799,597 |
Avg
Vol: |
866,060 |
| 52
Week Range: |
$191.51 - $228.9 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK™, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
55,541 |
485,736 |
| Total Sell Value |
$0 |
$0 |
$11,412,520 |
$88,282,436 |
| Total People Sold |
0 |
0 |
7 |
8 |
| Total Sell Transactions |
0 |
0 |
19 |
71 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Siegall Clay B |
President and CEO |
• • – |
2021-01-07 |
4 |
AS |
$167.39 |
$5,061,681 |
D/D |
(29,353) |
715,209 |
|
-16% |
|
| Siegall Clay B |
President and CEO |
• • – |
2021-01-07 |
4 |
OE |
$15.46 |
$453,797 |
D/D |
29,353 |
717,083 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2020-12-18 |
4 |
OE |
$26.10 |
$928,772 |
D/D |
34,773 |
119,871 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2020-12-18 |
4 |
AS |
$200.00 |
$6,733,800 |
D/D |
(33,669) |
118,767 |
|
-29% |
|
| Liu Jean I |
GC/EVP, Leg Affairs |
• – – |
2020-12-16 |
4 |
OE |
$35.95 |
$58,383 |
D/D |
1,624 |
60,266 |
|
- |
|
| Liu Jean I |
GC/EVP, Leg Affairs |
• – – |
2020-12-14 |
4 |
AS |
$193.72 |
$979,316 |
D/D |
(5,000) |
58,642 |
|
-24% |
|
| Liu Jean I |
GC/EVP, Leg Affairs |
• – – |
2020-12-14 |
4 |
OE |
$35.95 |
$179,750 |
D/D |
5,000 |
63,642 |
|
- |
|
| Himes Vaughn B |
Chief Technical Officer |
• – – |
2020-12-08 |
4 |
GA |
$0.00 |
$0 |
I/I |
53,669 |
53,669 |
|
- |
|
| Himes Vaughn B |
Chief Technical Officer |
• – – |
2020-12-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
61,800 |
129,790 |
|
- |
|
| Himes Vaughn B |
Chief Technical Officer |
• – – |
2020-12-07 |
4 |
AS |
$180.41 |
$1,454,041 |
D/D |
(8,000) |
191,590 |
|
-20% |
|
| Himes Vaughn B |
Chief Technical Officer |
• – – |
2020-12-07 |
4 |
OE |
$15.46 |
$323,646 |
D/D |
12,761 |
199,590 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2020-12-07 |
4 |
AS |
$178.36 |
$2,848,122 |
D/D |
(15,723) |
715,209 |
|
-20% |
|
| Siegall Clay B |
President and CEO |
• • – |
2020-12-07 |
4 |
OE |
$15.46 |
$243,078 |
D/D |
15,723 |
716,113 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2020-12-04 |
4 |
AS |
$179.17 |
$3,899,386 |
D/D |
(21,732) |
715,209 |
|
-19% |
|
| Siegall Clay B |
President and CEO |
• • – |
2020-12-04 |
4 |
OE |
$15.46 |
$335,977 |
D/D |
21,732 |
730,117 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2020-12-03 |
4 |
AS |
$176.18 |
$3,810,144 |
D/D |
(21,253) |
715,209 |
|
-17% |
|
| Siegall Clay B |
President and CEO |
• • – |
2020-12-03 |
4 |
OE |
$15.46 |
$328,571 |
D/D |
21,253 |
716,209 |
|
- |
|
| Romp Charles R |
EVP, Commercial |
• – – |
2020-12-03 |
4 |
S |
$179.30 |
$1,374,514 |
D/D |
(7,666) |
44,077 |
|
17% |
|
| Romp Charles R |
EVP, Commercial |
• – – |
2020-12-03 |
4 |
OE |
$39.15 |
$300,124 |
D/D |
7,666 |
51,743 |
|
- |
|
| Romp Charles R |
EVP, Commercial |
• – – |
2020-12-01 |
4 |
S |
$179.09 |
$1,074,539 |
D/D |
(6,000) |
44,077 |
|
21% |
|
| Romp Charles R |
EVP, Commercial |
• – – |
2020-12-01 |
4 |
OE |
$39.15 |
$234,900 |
D/D |
6,000 |
50,077 |
|
- |
|
| Gryska David W |
Director |
– • – |
2020-11-19 |
4 |
S |
$173.25 |
$2,605,523 |
D/D |
(15,000) |
44,848 |
|
18% |
|
| Gryska David W |
Director |
– • – |
2020-11-19 |
4 |
OE |
$19.02 |
$285,300 |
D/D |
15,000 |
52,719 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2020-11-05 |
4 |
S |
$180.37 |
$1,354,383 |
D/D |
(7,509) |
118,767 |
|
20% |
|
| Gryska David W |
Director |
– • – |
2020-11-05 |
4 |
S |
$180.60 |
$812,699 |
D/D |
(4,500) |
44,848 |
|
20% |
|
1805 Records found
|
|
Page 13 of 73 |
|
|
